Coltene Holding (CLTN.SW) Stock Price

Coltene Holding Price

SIX·CLOSED
47.80CHF-1.20 (-2.48 %)
Market closed

Revenue at Coltene Holding has contracted by 0.2% per year over the past 19 years to 240.05 M CHF. Earnings per share have declined at 3.5% per year over the last 19 years. Coltene Holding's net margin stands at 6.2%, down from 11.4% several years earlier. Coltene Holding currently offers a dividend yield of about 5.23%. The payout ratio is around 100% of earnings. The dividend has grown at 2.5% per year over the past 18 years. Analysts set a median price target of 58.14 CHF, implying 21.6% above the current price. Of 8 analysts, 6 rate the stock a buy — an overall Buy consensus. The stock trades about 11% above its 52-week low.

Coltene Holding stock price

Volume
Ex-Dividend
Details

Stock Price

ⓘ

How to Read This Chart

This chart tracks the historical stock price of Coltene Holding over time. You can switch between daily, weekly, and monthly views and select custom time ranges — from a single day to the full available history. Use the toggle to view price changes in absolute currency terms or as a percentage change relative to the starting date.

Total Return vs. Price Return

The "Total Return" toggle includes reinvested dividends on top of the pure price movement. This is critical because dividends can account for a significant portion of long-term returns. Historically, roughly 40 % of the S&P 500's total return has come from dividends. Always compare total return when evaluating a stock's real performance against a benchmark.

Intraday Price Data

When viewing a one-day time frame, the chart displays real-time intraday price movements. This is useful for observing how Coltene Holding stock reacts to market openings, earnings releases, or breaking news throughout the trading session.

What to Look For

Look for long-term trends (sustained upward or downward movements over months and years), support and resistance levels (price zones where the stock repeatedly bounces or reverses), and volatility (how much the price fluctuates day to day). Comparing Coltene Holding's price chart to a market index like the S&P 500 can reveal whether the stock is outperforming or underperforming the broader market.

Coltene Holding Stock Price History
DateColtene Holding Price
8/21/202647.80 CHF
8/20/202649.00 CHF
8/19/202647.80 CHF
8/18/202647.50 CHF
8/17/202647.10 CHF
8/14/202647.75 CHF
8/13/202647.35 CHF
8/12/202648.70 CHF
8/11/202649.30 CHF
8/10/202649.55 CHF
8/7/202650.50 CHF
8/6/202650.40 CHF
8/5/202649.70 CHF
8/4/202649.40 CHF
7/31/202648.90 CHF
7/30/202651.30 CHF
7/29/202651.20 CHF
7/28/202651.10 CHF
7/27/202651.10 CHF
7/24/202649.95 CHF
7/23/202652.30 CHF
7/22/202652.90 CHF
7/21/202652.20 CHF
7/20/202651.80 CHF
7/17/202652.30 CHF
7/16/202652.90 CHF
7/15/202651.90 CHF
7/14/202650.90 CHF
7/13/202650.40 CHF
7/10/202649.55 CHF
7/9/202650.70 CHF
7/8/202650.40 CHF
7/7/202651.70 CHF
7/6/202651.80 CHF
7/3/202652.40 CHF
7/2/202650.10 CHF
7/1/202651.00 CHF
6/30/202651.20 CHF
6/29/202650.00 CHF
6/26/202651.40 CHF
6/25/202652.50 CHF
6/24/202652.50 CHF
6/23/202651.20 CHF
6/22/202651.30 CHF
6/19/202651.00 CHF
6/18/202650.30 CHF
6/17/202650.90 CHF
6/16/202650.20 CHF
6/15/202650.10 CHF
6/12/202649.90 CHF
6/11/202648.80 CHF
6/10/202648.65 CHF
6/9/202647.80 CHF
6/8/202648.85 CHF
6/5/202648.70 CHF
6/4/202648.15 CHF
6/3/202648.95 CHF
6/2/202650.00 CHF
6/1/202649.35 CHF
5/29/202651.30 CHF
5/28/202650.70 CHF
5/27/202651.40 CHF
5/26/202651.40 CHF
5/22/202651.00 CHF
5/21/202650.10 CHF
5/20/202649.90 CHF
5/19/202648.45 CHF
5/18/202649.25 CHF
5/15/202647.85 CHF
5/13/202648.00 CHF
5/12/202648.00 CHF
5/11/202648.80 CHF
5/8/202649.00 CHF
5/7/202649.10 CHF
5/6/202649.40 CHF
5/5/202647.90 CHF
5/4/202647.45 CHF
4/30/202646.60 CHF
4/29/202646.60 CHF
4/28/202647.05 CHF
4/27/202648.70 CHF
4/24/202648.65 CHF
4/23/202649.80 CHF
4/22/202651.50 CHF
4/21/202651.60 CHF
4/20/202652.50 CHF
4/17/202653.10 CHF
4/16/202652.40 CHF
4/15/202652.00 CHF
4/14/202652.60 CHF
4/13/202650.70 CHF
4/10/202650.70 CHF
4/9/202650.90 CHF
4/8/202650.50 CHF
4/7/202648.15 CHF
4/2/202647.80 CHF
4/1/202648.00 CHF
3/31/202647.25 CHF
3/30/202646.40 CHF
3/27/202646.45 CHF
3/26/202647.00 CHF
3/25/202647.40 CHF
3/24/202646.30 CHF
3/23/202645.50 CHF
3/20/202645.80 CHF
3/19/202646.30 CHF
3/18/202647.15 CHF
3/17/202647.00 CHF
3/16/202647.00 CHF
3/13/202647.15 CHF
3/12/202648.20 CHF
3/11/202648.50 CHF
3/10/202648.95 CHF
3/9/202648.30 CHF
3/6/202650.90 CHF
3/5/202654.70 CHF
3/4/202655.30 CHF
3/3/202655.10 CHF
3/2/202656.20 CHF
2/27/202657.30 CHF
2/26/202656.90 CHF
2/25/202656.40 CHF
2/24/202656.80 CHF
2/23/202657.50 CHF
2/20/202657.80 CHF
2/19/202658.00 CHF
2/18/202658.20 CHF
2/17/202657.40 CHF
2/16/202654.20 CHF
2/13/202655.00 CHF
2/12/202654.30 CHF
2/11/202654.30 CHF
2/10/202655.80 CHF
2/9/202654.70 CHF
2/6/202654.90 CHF
2/5/202654.20 CHF
2/4/202654.50 CHF
2/3/202654.00 CHF
2/2/202654.40 CHF
1/30/202655.10 CHF
1/29/202655.90 CHF
1/28/202656.10 CHF
1/27/202655.50 CHF
1/26/202655.80 CHF
1/23/202656.60 CHF
1/22/202656.20 CHF
1/21/202653.90 CHF
1/20/202652.90 CHF
1/19/202652.80 CHF
1/16/202654.00 CHF
1/15/202658.10 CHF
1/14/202656.40 CHF
1/13/202655.30 CHF
1/12/202655.70 CHF
1/9/202655.80 CHF
1/8/202655.60 CHF
1/7/202654.80 CHF
1/6/202655.00 CHF
1/5/202655.00 CHF
12/30/202553.70 CHF
12/29/202554.30 CHF
12/23/202553.70 CHF
12/22/202553.20 CHF
12/19/202551.70 CHF
12/18/202552.10 CHF
12/17/202551.70 CHF
12/16/202553.10 CHF
12/15/202552.70 CHF
12/12/202553.00 CHF
12/11/202552.60 CHF
12/10/202551.20 CHF
12/9/202552.20 CHF
12/8/202551.30 CHF
12/5/202552.10 CHF
12/4/202552.20 CHF
12/3/202550.30 CHF
12/2/202550.90 CHF
12/1/202549.75 CHF
11/28/202549.90 CHF
11/27/202550.20 CHF
11/26/202549.75 CHF
11/25/202551.00 CHF
11/24/202549.55 CHF
11/21/202548.40 CHF
11/20/202546.25 CHF
11/19/202545.45 CHF
11/18/202545.35 CHF
11/17/202546.10 CHF
11/14/202548.60 CHF
11/13/202548.45 CHF
11/12/202547.55 CHF
11/11/202545.35 CHF
11/10/202545.25 CHF
11/7/202543.85 CHF
11/6/202543.00 CHF
11/5/202543.80 CHF
11/4/202544.50 CHF
11/3/202545.10 CHF
10/31/202545.25 CHF
10/30/202545.70 CHF
10/29/202545.45 CHF
10/28/202545.75 CHF
10/27/202546.30 CHF
10/24/202546.55 CHF
10/23/202546.50 CHF
10/22/202546.10 CHF
10/21/202545.30 CHF
10/20/202545.80 CHF
10/17/202545.20 CHF
10/16/202546.90 CHF
10/15/202546.25 CHF
10/14/202545.25 CHF
10/13/202546.60 CHF
10/10/202545.20 CHF
10/9/202545.55 CHF
10/8/202545.05 CHF
10/7/202544.60 CHF
10/6/202543.55 CHF
10/3/202545.50 CHF
10/2/202544.90 CHF
10/1/202544.45 CHF
9/30/202544.70 CHF
9/29/202545.20 CHF
9/26/202544.40 CHF
9/25/202545.15 CHF
9/24/202546.20 CHF
9/23/202546.75 CHF
9/22/202547.20 CHF
9/19/202548.00 CHF
9/18/202551.10 CHF
9/17/202550.20 CHF
9/16/202550.10 CHF
9/15/202550.60 CHF
9/12/202550.60 CHF
9/11/202550.20 CHF
9/10/202550.30 CHF
9/9/202550.60 CHF
9/8/202550.60 CHF
9/5/202550.50 CHF
9/4/202550.20 CHF
9/3/202550.50 CHF
9/2/202550.00 CHF
9/1/202551.80 CHF
8/29/202552.30 CHF
8/28/202552.00 CHF
8/27/202551.80 CHF
8/26/202551.30 CHF
8/25/202552.30 CHF
Access this data via the Eulerpool API
Get Free API Key

Coltene Holding Revenue, EBIT, Net Income

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details
Date
Revenue
EBIT
Net Income
Jan 1, 2022
267.13 M CHF
34.91 M CHF
26.00 M CHF
Jan 1, 2023
242.73 M CHF
19.61 M CHF
11.95 M CHF
Jan 1, 2024
250.16 M CHF
26.84 M CHF
20.47 M CHF
Jan 1, 2025
240.05 M CHF
20.49 M CHF
14.94 M CHF
Jan 1, 2026 (e)
236.81 M CHF
25.33 M CHF
16.63 M CHF
Jan 1, 2027 (e)
242.12 M CHF
25.85 M CHF
18.02 M CHF
Jan 1, 2028 (e)
244.88 M CHF
26.33 M CHF
18.27 M CHF
Jan 1, 2029 (e)
264.80 M CHF
28.47 M CHF
0.00 CHF

Coltene Holding Income Statement, Balance Sheet, Cash Flow Statement

Last updated Aug 22, 2026, 6:59 PM
 
REVENUEM CHF
REVENUE GROWTH%
GROSS MARGIN%
GROSS INCOMEM CHF
EBITM CHF
EBIT MARGIN%
NET INCOMEM CHF
NET INCOME GROWTH%
DIV.CHF
DIV. GROWTH%
SHARESM
2014201520162017201820192020202120222023202420252026e2027e2028e2029e
162.00154.00160.00167.00203.00273.00248.00279.00267.00242.00250.00240.00236.00242.00244.00264.00
1.25-4.943.904.3821.5634.48-9.1612.50-4.30-9.363.31-4.00-1.672.540.838.20
70.3769.4871.8871.8668.9765.2064.5263.4462.9224.3862.4025.4225.4225.4225.4225.42
114.00107.00115.00120.00140.00178.00160.00177.00168.0059.00156.0061.0059.9861.5162.0267.10
22.0020.0023.0025.0023.0032.0023.0043.0034.0019.0026.0020.0025.0025.0026.0028.00
13.5812.9914.3714.9711.3311.729.2715.4112.737.8510.408.3310.5910.3310.6610.61
15.0013.0017.0019.0014.0020.008.0031.0025.0011.0020.0014.0016.0018.0018.00–
15.38-13.3330.7711.76-26.3242.86-60.00287.50-19.35-56.0081.82-30.0014.2912.50––
1.922.502.202.703.003.001.503.003.303.302.002.502.773.073.40–
6.6730.21-12.0022.7311.11–-50.00100.0010.00–-39.3925.0010.8010.8310.75–
4.234.204.214.225.215.985.985.985.985.985.985.985.985.985.985.98
Details

Income Statement Key Figures

ⓘ

Revenue and Revenue Growth

Revenue is the starting point of every income statement — it measures the total sales Coltene Holding generates from its core business. Revenue growth (expressed as year-over-year percentage change) is one of the most important indicators of business momentum. Sustained growth above 10 % annually is generally considered strong, while declining revenue is a serious warning sign that demands investigation.

Gross Margin

Gross margin = (Revenue − Cost of Goods Sold) ÷ Revenue. It reveals what percentage of each dollar of revenue Coltene Holding retains after direct production costs. High gross margins (above 50 %) are typical of asset-light businesses like software and brands, while capital-intensive industries like manufacturing often operate below 30 %. Compare Coltene Holding's gross margin to industry peers and track it over time to spot improving or deteriorating pricing power.

EBIT and EBIT Margin

EBIT measures operating profit — what remains after subtracting all operating expenses (including R&D, sales, and administrative costs) from gross profit. The EBIT margin shows this as a percentage of revenue. Because it excludes interest and taxes, EBIT allows fair comparisons between companies with different debt levels and tax jurisdictions. A rising EBIT margin indicates improving operational efficiency.

Net Income and Earnings Per Share (EPS)

Net income is the company's final profit after all expenses, interest, and taxes. Dividing net income by the number of shares outstanding gives you EPS — the single most influential metric in stock valuation. Consistent EPS growth is the primary driver of long-term stock price appreciation. Always check whether EPS growth comes from genuine profit improvement or from share buybacks reducing the share count.

Shares Outstanding

The total number of shares Coltene Holding has issued. A declining share count (through buybacks) boosts EPS and signals management confidence. A rising share count (through stock issuance) dilutes existing shareholders. Always monitor this number alongside EPS to get the full picture of per-share value creation.

Analyst Estimates

The projected figures represent consensus estimates from professional analysts. Compare these forecasts against Coltene Holding's historical growth rates to assess whether expectations are realistic. A company that consistently beats consensus estimates tends to see its stock price rewarded over time, while repeated misses erode investor confidence.

Coltene Holding stock margins

The Coltene Holding margin analysis displays the gross margin, EBIT margin, as well as the profit margin of Coltene Holding. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for Coltene Holding.

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details
Date
Gross margin
EBIT margin
Profit margin
Jan 1, 2021
63.43 %
15.68 %
11.36 %
Jan 1, 2022
63.05 %
13.07 %
9.73 %
Jan 1, 2023
24.58 %
8.08 %
4.92 %
Jan 1, 2024
62.74 %
10.73 %
8.18 %
Jan 1, 2025
25.64 %
8.53 %
6.23 %
Jan 1, 2026 (e)
25.64 %
10.70 %
7.02 %
Jan 1, 2027 (e)
25.64 %
10.68 %
7.44 %
Jan 1, 2028 (e)
25.64 %
10.75 %
7.46 %

Coltene Holding Stock Revenue, EBIT, Earnings per Share

The Coltene Holding earnings per share therefore indicates how much revenue Coltene Holding has generated per share in a given period. The earnings before interest and taxes per share shows how much of the operating profit corresponds to each share. The earnings per share indicates how much of the profit belongs to each share.

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Revenue per Share
EBIT per share
Earnings per Share
Details
Date
Revenue per Share
EBIT per share
Earnings per Share
Jan 1, 2021
46.73 CHF
7.33 CHF
5.31 CHF
Jan 1, 2022
44.71 CHF
5.84 CHF
4.35 CHF
Jan 1, 2023
40.62 CHF
3.28 CHF
2.00 CHF
Jan 1, 2024
41.87 CHF
4.49 CHF
3.43 CHF
Jan 1, 2025
40.17 CHF
3.43 CHF
2.50 CHF
Jan 1, 2026 (e)
39.60 CHF
4.24 CHF
2.78 CHF
Jan 1, 2027 (e)
40.49 CHF
4.33 CHF
3.01 CHF
Jan 1, 2028 (e)
40.95 CHF
4.41 CHF
3.05 CHF

Coltene Holding business model & stock analysis

Coltene Holding AG is a Swiss company that has been active on the market for nearly 60 years. Founded in 1958, Coltene has become a leading manufacturer of dental consumables and medical technology. The company is internationally active and has its headquarters in Altstätten, Switzerland. It is divided into various business divisions that focus on the production and distribution of products for dentistry, endodontics, and dental technology. Coltene's business model consists of offering its customers innovative, high-quality, and efficient products that meet the needs of both dentists and patients. Through continuous research and development and close collaboration with customers, the company maintains its leading position in the market. Coltene is divided into four different business divisions: dental consumables, endodontics, dental technology, and services. Dental consumables include products such as composite filling materials, adhesives, bonding agents, fixing materials, prophylaxis products, and impression materials. The endodontics division includes products such as files, endo motors, root canal strengtheners, and other instruments used in root canal treatment. Coltene's dental technology division focuses on manufacturing devices that facilitate and improve the work of dentists. This includes dental microscopes, dental chairs, treatment units, and orthodontic equipment. Coltene also offers services such as training and further education for dentists and dental professionals. The company places great value on the continuing education of its customers to ensure that the products can be optimally applied. In recent years, Coltene has also expanded its product portfolio to include products for neurosurgery, ophthalmology, and ENT. The success of Coltene is based on its ability to meet the needs of its customers and develop high-quality products. The company sets the highest standards in quality assurance of its products and customer satisfaction. Overall, Coltene is one of the leading companies in the dental industry and has also expanded into other medical fields in recent years. Its innovative and advanced product range, and its ability to meet the needs of customers, make Coltene a trusted partner for dentists and other medical professionals worldwide.

Coltene Holding SWOT Analysis

Strengths

Coltene Holding AG has several strengths that contribute to its success in the market. Firstly, the company has a strong brand reputation and is recognized as a leading provider of dental consumables and solutions. This brand recognition helps Coltene attract and retain customers. Secondly, Coltene has a diverse range of high-quality products in its portfolio. This enables the company to meet the varied needs of dental professionals and offer innovative solutions for different dental procedures. Additionally, Coltene has a global presence with a strong distribution network. This ensures that its products are readily available to customers worldwide and allows the company to tap into various international markets. Furthermore, Coltene has a dedicated and skilled workforce. The company invests in employee training and development, resulting in a team that is knowledgeable and capable of providing exceptional customer service. Lastly, Coltene has a strong financial position and consistent revenue growth. This provides the company with the resources needed for research and development, as well as expansion and investment opportunities.

Weaknesses

Despite its strengths, Coltene Holding AG also faces some weaknesses that may hinder its growth and performance. One major weakness is its dependency on the dental industry. Any changes or fluctuations in the dental market can directly impact the company's sales and profitability. Another weakness is the potential for increased competition in the market. The dental industry is highly competitive, with several established players and new entrants. Coltene must continuously innovate and differentiate its products to maintain its market share and stay ahead of competitors. Additionally, Coltene's global presence exposes it to currency exchange rate risks. Fluctuations in exchange rates can affect the company's profitability when converting foreign currency into its reporting currency. Lastly, Coltene's product portfolio may lack diversification in terms of non-dental healthcare solutions. This limited diversification exposes the company to potential risks from changes in the dental industry or market preferences.

Opportunities

Despite the challenges, Coltene Holding AG can leverage various opportunities in the market. Firstly, the increasing demand for dental treatments and the overall growth of the dental industry present a significant opportunity for Coltene to expand its customer base and increase sales. Secondly, there is a growing focus on aesthetics and cosmetic dentistry, which opens up new market segments for Coltene. By developing and marketing innovative and high-quality products specifically tailored to this segment, the company can capture a larger share of this lucrative market. Furthermore, Coltene can explore strategic partnerships and collaborations with other healthcare companies. By combining resources and expertise, Coltene can develop integrated solutions that offer comprehensive dental care and attract more customers. Lastly, Coltene has the potential to expand its product portfolio beyond dental consumables and solutions. By diversifying into related areas of healthcare, such as orthodontics or oral care, the company can tap into new revenue streams and reduce its dependency on the dental industry.

Threats

Coltene Holding AG faces several threats that may impact its business operations and performance. One major threat is the strict regulatory environment in the dental industry. Compliance with regulations and obtaining necessary approvals for products can be time-consuming and costly for the company. Additionally, the entry of low-cost competitors, especially from emerging markets, poses a threat to Coltene's market share. These low-cost alternatives may attract price-sensitive customers and erode Coltene's profitability. Furthermore, advancements in technology and materials may disrupt the dental industry and render some of Coltene's products obsolete. Staying updated with technological advancements and investing in research and development is crucial to mitigate this threat. Lastly, the ongoing COVID-19 pandemic has negatively impacted the dental industry, leading to reduced dental visits and lower demand for dental consumables. This external factor has put pressure on Coltene's revenue and profitability, highlighting the vulnerability of the company to external shocks and crises.

Coltene Holding Eulerpool Fair Value

Details

Fair Value Estimate

ⓘ

What Is Fair Value?

Fair value is an estimate of what a stock is truly "worth" based on its financial fundamentals, independent of the current market price. If the calculated fair value is above the current share price, the stock may be undervalued — and vice versa. This chart shows three different fair value approaches so you can cross-check them against each other.

Earnings-Based Fair Value

Calculated by multiplying the current earnings per share (EPS) by the average historical P/E ratio over a selected multi-year period. The smoothing over several years filters out temporary spikes or dips. If this fair value exceeds the market price, it suggests the stock is cheap relative to its earning power.

Example: Fair Value (Earnings) 2022 = EPS 2022 × Average P/E 2019–2021

Revenue-Based Fair Value

Derived by multiplying revenue per share by the average historical price-to-sales ratio. This method is particularly useful for companies with volatile or temporarily depressed earnings, as revenue tends to be more stable than profits. It answers: "At what price has the market historically valued each dollar of this company's sales?"

Example: Fair Value (Revenue) 2022 = Revenue per Share 2022 × Average P/S 2019–2021

Dividend-Based Fair Value

Calculated by dividing the dividend per share by the average historical dividend yield. This approach is most relevant for mature, consistently dividend-paying companies. If the resulting fair value is higher than the current price, it implies the stock offers a better yield than its historical average.

Example: Fair Value (Dividend) 2022 = Dividend per Share 2022 ÷ Average Yield 2019–2021

How to Use This Chart

When all three fair value lines converge above the current price, it strengthens the case that the stock is undervalued. When they diverge, investigate why — it may indicate a structural shift in margins, payout policy, or growth rate. The forward estimates on the right extend the analysis using projected fundamentals, helping you assess whether the current price already reflects future growth expectations.

Coltene Holding historical P/E ratio, EBIT multiple, and P/S ratio

Coltene Holding annual returns

Details

Annual Return

ⓘ

What This Chart Shows

This chart breaks down 's total annual return into two components: price return (gains or losses from stock price movement) and dividend return (income received from dividend payments). Together, they represent the total return an investor would have earned in each calendar year.

Price Return

Price return measures the percentage change in 's stock price from January 1st to December 31st of each year. Positive bars indicate the stock appreciated; negative bars show a decline. This is the component most investors focus on, but it tells only part of the story — especially for dividend-paying stocks.

Dividend Return

Dividend return represents the income generated from dividends paid during the year, expressed as a percentage of the starting stock price. While it may seem small in any single year (typically 1–4 % for established companies), dividends compound significantly over decades and have historically contributed roughly 40 % of total stock market returns.

What to Look For

Examine how many years showed positive vs. negative returns to gauge consistency. A stock with mostly positive years and small drawdowns suggests lower risk. Also compare 's annual returns to a benchmark index — consistently outperforming the market is a hallmark of a strong investment. Pay attention to the worst years: understanding downside risk is just as important as chasing upside potential.

Coltene Holding shares outstanding

The number of shares of Coltene Holding was 5.98 M in 2025. This indicates how many shares Coltene Holding is divided into. Since shareholders are the owners of a company, each share represents a small portion of the company's ownership.

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Number of stocks
Details
Date
Number of stocks
Jan 1, 2021
5.98 M Stocks
Jan 1, 2022
5.98 M Stocks
Jan 1, 2023
5.98 M Stocks
Jan 1, 2024
5.98 M Stocks
Jan 1, 2025
5.98 M Stocks
Jan 1, 2026 (e)
5.98 M Stocks
Jan 1, 2027 (e)
5.98 M Stocks
Jan 1, 2028 (e)
5.98 M Stocks

Coltene Holding Dividend History

19 years of dividend payments

YearAnnual DividendYoY ChangePayments
20252.50CHF↑ 25.0%1×
Apr 25, 20252.50CHF↑ 25.0%1/1
20242.00CHF↓ 39.4%1×
20233.30CHF 0.0%1×
20223.30CHF↑ 10.0%1×
20213.00CHF↑ 100.0%1×
20201.50CHF↓ 50.0%1×
20193.00CHF 0.0%1×
20183.00CHF↑ 11.1%1×
20172.70CHF↑ 22.7%1×
20162.20CHF↓ 12.0%1×

Coltene Holding dividend history and estimates

In 2025, Coltene Holding paid a dividend amounting to 2.50 CHF. Dividend means that Coltene Holding distributes a portion of its profits to its owners.

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Dividend
Dividend (Estimate)
Details
Date
Dividend
Dividend (Estimate)
Special dividend
Jan 1, 2021
3.00 CHF
0.00 CHF
0.00 CHF
Jan 1, 2022
3.30 CHF
0.00 CHF
0.00 CHF
Jan 1, 2023
3.30 CHF
0.00 CHF
0.00 CHF
Jan 1, 2024
2.00 CHF
0.00 CHF
0.00 CHF
Jan 1, 2025
2.50 CHF
0.00 CHF
0.00 CHF
Jan 1, 2026 (e)
0.00 CHF
2.77 CHF
0.00 CHF
Jan 1, 2027 (e)
0.00 CHF
3.07 CHF
0.00 CHF
Jan 1, 2028 (e)
0.00 CHF
3.40 CHF
0.00 CHF

Coltene Holding dividend payout ratio

In 2025, Coltene Holding had a payout ratio of 99.97%. The payout ratio indicates the percentage of the company's profits that Coltene Holding distributes as dividends.

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Payout ratio
Details
Date
Payout ratio
Jan 1, 2021
56.54 %
Jan 1, 2022
75.84 %
Jan 1, 2023
165.06 %
Jan 1, 2024
58.39 %
Jan 1, 2025
99.97 %
Jan 1, 2026 (e)
99.59 %
Jan 1, 2027 (e)
101.77 %
Jan 1, 2028 (e)
111.19 %

Current Coltene Holding forecasts and price targets in August 2026

Analyst Price Targets 2026
Δ MOM Price Target
0.00 %
Buy
75.00 % (6)
Hold
25.00 % (2)
Sell
0.00 % (0)
12M Price Target
58.14
Last Price
47.80
Currency
CHF
12M Return Potential
21.63 %
LTM Return
0 %

Coltene Holding Earnings Estimates & Surprises

DateEPS estimateEPS ActualRevenue EstimatePrice reactionQuarterly report
3/18/2010-CHF-86.75 MCHF-2009 Q4
8/20/2009-CHF-72.61 MCHF-2009 Q2
3/18/2009-CHF-83.74 MCHF-2008 Q4

EESG©

Eulerpool ESG Scorecard© for the Coltene Holding stock

70/100
55
Environment
99
Social
57
Governance
E

Environment

20
Scope 1 - Direct Emissions1,749
Scope 2 - Indirect emissions from purchased energy1,233
Scope 3 - Indirect emissions within the value chain—
Total CO₂ emissions2,982
CO₂ reduction strategy
Coal energy
Nuclear power
Animal experiments
Fur & Leather—
Pesticides—
Palm Oil—
Tobacco
Genetically modified organisms
Climate concept—
Sustainable forestry—
Recycling regulations
Environmentally friendly packaging
Hazardous substances
Fuel consumption and efficiency
Water consumption and efficiency
S

Social

20
Percentage of female employees46
Percentage of women in management—
Percentage of Asian employees—
Share of Asian management—
Percentage of Hispanic/Latino employees—
Hispano/Latino Management share—
Percentage of Black employees—
Black Management Share—
Percentage of white employees—
White Management Share—
Adult content
Alcohol
Weapons—
Firearms
Gambling
Military contracts
Human rights concept
Privacy concept—
Occupational health and safety
Catholic
G

Governance (Corporate Governance)

4
Environmental reporting
Stakeholder Engagement
Call Back Policies
Antitrust law

The Eulerpool ESG Scorecard© is the strictly copyrighted intellectual property of Eulerpool Research Systems. Any unauthorized use, imitation, or infringement will be actively pursued and may lead to significant legal consequences. For licenses, collaborations, or usage rights, please contact us directly via our contact form. Contact Form to us.

Coltene Holding shareholder structure

% Name
5.01487%
UBS Asset Management (Switzerland)
UBS Asset Management (Switzerland)
2.48622%
Tweedy, Browne Company LLC
Tweedy, Browne Company LLC
0.92773%
Basler Kantonalbank
Basler Kantonalbank
0.83768%
UBS Asset Management Switzerland AG
UBS Asset Management Switzerland AG
0.78431%
Zürcher Kantonalbank (Asset Management)
Zürcher Kantonalbank (Asset Management)
0.71323%
Dimensional Fund Advisors, L.P.
Dimensional Fund Advisors, L.P.

Coltene Holding Beneficial Ownership Filings (SEC 13D/G)

Free Float
43.0%
Float Shares
-
Shares Outstanding
-

Coltene Holding Executives and Management Board

14 members · avg. age 54 · 14 % women

DA

Mr. Dominik Arnold (53)

Chief Executive Officer, Member of the Management Board

889,119.00 CHF

Management

MA

Mr. Markus Abderhalden (46)

Chief Financial Officer, Member of the Management Board

–
GP

Mr. Gregor Picard (55)

Chief Operating Officer, Member of the Management Board

–
MS

Dr. Martin Schlueter (53)

Chief Technology Officer, Member of the Management Board

–
MF

Mr. Mattias Flodin (51)

Chief Marketing Officer, Member of the Management Board

–
PF

Mr. Paul Frey (50)

Chief Sales Officer, North America, Member of the Management Board

–
DH

Mr. Di Hu (48)

Chief Sales Officer, Europe and Rest of the World, Member of the Management Board

–

Board of Directors

NH

Mr. Nick Huber (61)

Non-Executive Chairman of the Board of Directors

115,308.00 CHF
AW

Dr. Astrid Waser (54)

Non-Executive Member of the Board of Directors

92,031.00 CHF
MA

Mr. Matthias Altendorf (58)

Non-Executive Member of the Board of Directors

80,572.00 CHF
DB

Mr. Daniel Buhler (59)

Non-Executive Member of the Board of Directors

80,572.00 CHF
AZ

Dr. Allison Zwingenberger (55)

Non-Executive Member of the Board of Directors

80,572.00 CHF
JR

Mr. Juergen Rauch (58)

Non-Executive Member of the Board of Directors

80,436.00 CHF

Coltene Holding Supply Chain

Coltene Holding Supply Chain

Correlation: how closely stock prices move together

Same directionNo relationOpposite
1 companies
#NameTrend
1
Covetrus Inc
Customer·Health Care Providers & Services·US
-0.66
-0.08
0.16
0.57
0.82
0.09

Frequently asked questions about Coltene Holding

The business model of Coltene Holding AG is focused on developing, manufacturing, and marketing dental consumables and small equipment for dentists and dental technicians. Coltene offers a wide range of products including dental restorative materials, endodontic instruments, dental cements, and prosthetic materials. They also provide treatment concepts, software solutions, and other services to support dental professionals in their practices. With a commitment to innovation, quality, and customer satisfaction, Coltene aims to continually enhance and expand their product portfolio to meet the evolving needs of the dental industry. Coltene Holding AG is a leading global provider of dental solutions.

Coltene Holding AG is primarily active in the dental industry.

Coltene Holding AG faces competition from various companies in the market. Some of the main competitors of Coltene Holding AG include Dentsply Sirona, Straumann Holding AG, 3M Company, Ivoclar Vivadent AG, and Zimmer Biomet Holdings, Inc. These companies also operate in the dental industry, providing products and services similar to Coltene Holding AG. While Coltene Holding AG strives to differentiate itself through innovative solutions and high-quality dental materials, it continuously monitors and adapts to the competitive landscape to maintain its position in the market.

Coltene Holding AG is a renowned dental company with a rich history and background. Founded in 1959, Coltene has continually evolved and expanded its product offering in the dental industry. With headquarters in Switzerland, it has become a global leader in the development, manufacturing, and sale of dental consumables and equipment. Coltene is dedicated to providing innovative solutions to dental professionals, including dental materials, restoration instruments, endodontic products, and digital dentistry solutions. Their commitment to quality, customer satisfaction, and technological advancements has enabled Coltene to establish a strong presence worldwide in the dental market.

Coltene Holding AG, a prominent stock, has achieved several significant milestones. One was the successful launch of the groundbreaking ParaPost® Fiber Lux in 2009, enhancing its dental product portfolio. Another milestone was in 2011, when Coltene acquired MicroMega, a leading French manufacturer of endodontics products, expanding its market presence. Moreover, in 2013, Coltene developed the breakthrough HyFlex™ CM rotary file system, revolutionizing endodontic treatment. This company has consistently demonstrated its commitment to innovation and growth, solidifying its position as an industry leader. With these achievements, Coltene Holding AG continues to pave the way for advancements in the dental field.

Coltene Holding AG is primarily present in various countries and regions around the world. With its global reach, the company has established a strong presence in Europe, North America, Asia-Pacific, and the Middle East. Coltene Holding AG serves its customers and partners in countries such as Switzerland, Germany, the United States, China, India, Japan, and the United Arab Emirates, among others. This global presence allows Coltene Holding AG to effectively cater to the dental and healthcare industry on an international scale, delivering its high-quality products and services to diverse markets worldwide.

Coltene Holding AG represents values of quality, innovation, and patient care. With a strong corporate philosophy, Coltene is committed to delivering dental solutions that enhance oral health worldwide. The company focuses on continuously developing technologically advanced products and solutions that meet the highest industry standards. Coltene Holding AG prioritizes customer satisfaction by providing reliable, precise, and efficient dental materials and equipment. By incorporating cutting-edge research, development, and manufacturing processes, Coltene ensures exceptional quality and long-lasting dental solutions. With a dedication to excellence, Coltene Holding AG aims to improve dental professionals' workflow and ultimately enhance patient experience in the dental industry.

Analysts currently set an average price target of 58.14 CHF for the Coltene Holding stock (median: 58.14 CHF), implying +21.6 % versus the latest price. The consensus is based on 8 analyst ratings.

Coltene Holding Analyst Price Targets 2026

8 analysts currently rate the Coltene Holding stock: 6 recommend buying, 2 holding and 0 selling. For 2026, analysts expect Coltene Holding to generate revenue of 236.81 M CHF and earnings per share of 2.78 CHF.

Coltene Holding Analyst Price Targets 2026

Converted at the current exchange rate, the Coltene Holding share trades at 51.09 EUR (47.80 CHF).

The Coltene Holding share (CLTN.SW) is listed on 4 stock exchanges, including: Frankfurt (M3Z.F), London (0QP7.L), London (0QP7.L), SIX (Zürich) (CLTN.SW).

The Coltene Holding AG is an internationally active company specializing in the development, manufacturing, and distribution of dental products. Based in Altstätten, Switzerland, the company has been operating for over 60 years in more than 90 countries worldwide, making it one of the leading providers in this field. Coltene's business model includes various divisions and products. One of Coltene's core divisions is the production of materials for dentistry. The company offers a wide range of high-quality, precise, and safe materials for dental prophylaxis and restorative treatment. These include adhesives, composites, bonding materials, impression materials, as well as sealing and filling materials. The products of the brands BRILLIANT Crios, COLTENE, and DMG are particularly well-known. Another important component of Coltene's business model is the development and manufacturing of instruments and devices for dental practices. These include root canal instruments, rotary instruments, files, scalers, impression trays, mouth mirrors, as well as turbines and motors. Here too, the focus is on the highest quality, precision, and efficiency. Coltene also focuses on innovation in the field of digitization. For example, the company produces digital impression and planning systems such as CEREC, CEREC Omnicam, and iTero. These systems enable the precise capture of dental structures and greatly facilitate the work of dentists. In the division of dental hygiene and prophylaxis, Coltene offers numerous products for cleaning and caring for teeth and the oral cavity. These include toothbrushes, interdental brushes, dental floss, mouthwashes, and many other products that contribute to improving oral hygiene and preventing diseases such as cavities or periodontitis. Another component of Coltene's business model is the area of research and development. The company works closely with universities and research institutions to develop innovative products and solutions for dentistry. The focus is particularly on the use of state-of-the-art technologies and materials, as well as the continuous optimization of products. In summary, Coltene's business model is based on a broad range of products in the field of dentistry. The company offers high-quality materials, instruments, and devices, as well as innovative digital solutions and products for oral hygiene and prophylaxis. Coltene always prioritizes the highest quality, precision, and efficiency, also in the areas of research and development.

The expected revenue of Coltene Holding is 236.81 M CHF. This figure is based on current financial data and reflects the company's business performance.

The expected profit of Coltene Holding is 16.63 M CHF. The net profit reflects the company's profitability after deducting all expenses.

The price-to-earnings ratio (P/E) of Coltene Holding is currently 17.18. The P/E ratio compares the current share price to the earnings per share and helps investors assess the valuation of the Coltene Holding stock.

The price-to-sales ratio (P/S) of Coltene Holding is currently 1.21. The P/S ratio compares the market capitalization to the annual revenue and serves as a valuation metric for the Coltene Holding stock.

The Eulerpool Quality Score for Coltene Holding is 2/10.

The ISIN of Coltene Holding is CH0025343259. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.

The WKN of Coltene Holding is A0J3ED. The WKN (Wertpapierkennnummer) is a six-digit German security identification number.

The ticker of Coltene Holding is CLTN.SW. The ticker symbol is used to trade Coltene Holding shares on the stock exchange.

Over the past 12 months, Coltene Holding paid a dividend of 2.50 CHF . This corresponds to a dividend yield of about 5.23 %. For the coming 12 months, Coltene Holding is expected to pay a dividend of 3.07 CHF.

The current dividend yield of Coltene Holding is 5.23 %.

Coltene Holding pays a dividend, distributed in the months of , , , .

Coltene Holding paid dividends every year for the past 19 years.

For the upcoming 12 months, dividends amounting to 3.07 CHF are expected. This corresponds to a dividend yield of 6.42 %.

Coltene Holding is assigned to the 'Health' sector.

To receive the latest dividend of Coltene Holding from amounting to 2.5 CHF, you needed to have the stock in your portfolio before the ex-date on .

The last dividend was paid out on .

In the year 2025, Coltene Holding distributed 2 CHF as dividends.

The dividends of Coltene Holding are distributed in CHF.

All fundamentals and in-depth analysis of Coltene Holding

Our stock analysis for Coltene Holding stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Coltene Holding. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.

Coltene Holding Stock
Coltene Holding Revenue→
Coltene Holding Stock
Coltene Holding Net Income→
Coltene Holding Stock
Coltene Holding P/E→
Coltene Holding Stock
Coltene Holding P/S→
Coltene Holding Stock
Coltene Holding EBIT→
Coltene Holding Stock
Coltene Holding Dividend→
Coltene Holding Stock
Coltene Holding Directors Dealings→
Coltene Holding Stock
Coltene Holding Stocks→
Coltene Holding Stock
Coltene Holding Market capitalization→
Coltene Holding Stock
Coltene Holding Debt→
Coltene Holding Stock
Coltene Holding Liabilities→
Coltene Holding Stock
Coltene Holding Equity→
Coltene Holding Stock
Coltene Holding AAQS→
Coltene Holding Stock
Coltene Holding Employees→
Coltene Holding Stock
Coltene Holding ROE→
Coltene Holding Stock
Coltene Holding ROA→
Coltene Holding Stock
Coltene Holding ROCE→
Coltene Holding Stock
Coltene Holding News→
Coltene Holding Stock
Coltene Holding Analyst Price Targets→

Health Stocks

Comera Life Sciences HoldingsColoplast A/SCommunity Health SystemsCollplant BiotechnologiesCompass PathwaysCollegium PharmaceuticalCompass TherapeuticsColinz LaboratoriesCompugenColan Totte CoCompuMedCoherus OncologyAll Stocks A–Z →